These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 26475514)

  • 1. Detection of active human papilloma virus-16 in head and neck cancers of Asian North Indian patients.
    Sannigrahi MK; Singh V; Sharma R; Panda NK; Radotra BD; Khullar M
    Oral Dis; 2016 Jan; 22(1):62-8. PubMed ID: 26475514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus E7 serology and association with p16 immunohistochemistry in squamous cell carcinoma of the head and neck.
    Khanal S; Joh J; Kwon AM; Zahin M; Perez CA; Dunlap NE; Silverman CL; Tennant PA; Potts KL; Kloecker GH; Bumpous JM; Ghim SJ; Jenson AB; Redman RA
    Exp Mol Pathol; 2015 Oct; 99(2):335-40. PubMed ID: 26116154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis.
    Ndiaye C; Mena M; Alemany L; Arbyn M; Castellsagué X; Laporte L; Bosch FX; de Sanjosé S; Trottier H
    Lancet Oncol; 2014 Nov; 15(12):1319-31. PubMed ID: 25439690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus and human papillomavirus infections and genotype distribution in head and neck cancers.
    Deng Z; Uehara T; Maeda H; Hasegawa M; Matayoshi S; Kiyuna A; Agena S; Pan X; Zhang C; Yamashita Y; Xie M; Suzuki M
    PLoS One; 2014; 9(11):e113702. PubMed ID: 25405488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA in-situ hybridization is a practical and effective method for determining HPV status of oropharyngeal squamous cell carcinoma including discordant cases that are p16 positive by immunohistochemistry but HPV negative by DNA in-situ hybridization.
    Rooper LM; Gandhi M; Bishop JA; Westra WH
    Oral Oncol; 2016 Apr; 55():11-6. PubMed ID: 27016012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of human papillomavirus in p16-positive oral cancers.
    Belobrov S; Cornall AM; Young RJ; Koo K; Angel C; Wiesenfeld D; Rischin D; Garland SM; McCullough M
    J Oral Pathol Med; 2018 Jan; 47(1):18-24. PubMed ID: 29024035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus in oropharyngeal squamous cell carcinoma: assessing virus presence in normal tissue and activity in cervical metastasis.
    Laborde RR; Janus JR; Olsen SM; Wang VW; Garcia JJ; Graham RP; Moore EJ; Olsen KD; Kasperbauer JL; Price DL; Berres M; Halling G; Smith DI
    Laryngoscope; 2012 Dec; 122(12):2707-11. PubMed ID: 22961429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aurora kinases are a novel therapeutic target for HPV-positive head and neck cancers.
    Shaikh MH; Idris A; Johnson NW; Fallaha S; Clarke DTW; Martin D; Morgan IM; Gabrielli B; McMillan NAJ
    Oral Oncol; 2018 Nov; 86():105-112. PubMed ID: 30409290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low prevalence of transcriptionally active human papilloma virus in Indian patients with HNSCC and leukoplakia.
    Bhosale PG; Pandey M; Desai RS; Patil A; Kane S; Prabhash K; Mahimkar MB
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Nov; 122(5):609-618.e7. PubMed ID: 27765330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of mucosal high-risk human papillomavirus types in head and neck cancers in central India.
    Gheit T; Anantharaman D; Holzinger D; Alemany L; Tous S; Lucas E; Prabhu PR; Pawlita M; Ridder R; Rehm S; Bogers J; Maffini F; Chiocca S; Lloveras B; Kumar RV; Somanathan T; de Sanjosé S; Castellsagué X; Arbyn M; Brennan P; Sankaranarayanan R; Pillai MR; Gangane N; Tommasino M;
    Int J Cancer; 2017 Jul; 141(1):143-151. PubMed ID: 28369859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of detection methods for HPV status as a prognostic marker for loco-regional control after radiochemotherapy in patients with HNSCC.
    Linge A; Schötz U; Löck S; Lohaus F; von Neubeck C; Gudziol V; Nowak A; Tinhofer I; Budach V; Sak A; Stuschke M; Balermpas P; Rödel C; Bunea H; Grosu AL; Abdollahi A; Debus J; Ganswindt U; Lauber K; Pigorsch S; Combs SE; Mönnich D; Zips D; Baretton GB; Buchholz F; Krause M; Belka C; Baumann M;
    Radiother Oncol; 2018 Apr; 127(1):27-35. PubMed ID: 29295747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p16(INK4a) overexpression predicts translational active human papillomavirus infection in tonsillar cancer.
    Hoffmann M; Ihloff AS; Görögh T; Weise JB; Fazel A; Krams M; Rittgen W; Schwarz E; Kahn T
    Int J Cancer; 2010 Oct; 127(7):1595-602. PubMed ID: 20091864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of High-Risk Human Papillomavirus DNA, p16, and E6/E7 Oncoproteins in Laryngeal and Hypopharyngeal Squamous Cell Carcinomas.
    Lifsics A; Groma V; Cistjakovs M; Skuja S; Deksnis R; Murovska M
    Viruses; 2021 May; 13(6):. PubMed ID: 34072187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of human papilloma virus in oral tongue squamous cell carcinoma.
    Elango KJ; Suresh A; Erode EM; Subhadradevi L; Ravindran HK; Iyer SK; Iyer SK; Kuriakose MA
    Asian Pac J Cancer Prev; 2011; 12(4):889-96. PubMed ID: 21790221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus/p16 positive head and neck cancer in India: Prevalence, clinical impact, and influence of tobacco use.
    Murthy V; Swain M; Teni T; Pawar S; Kalkar P; Patil A; Chande A; Ghonge S; Laskar SG; Gupta T; Budrukkar A; Agrawal J
    Indian J Cancer; 2016; 53(3):387-393. PubMed ID: 28244466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral load, physical status, and E6/E7 mRNA expression of human papillomavirus in head and neck squamous cell carcinoma.
    Deng Z; Hasegawa M; Kiyuna A; Matayoshi S; Uehara T; Agena S; Yamashita Y; Ogawa K; Maeda H; Suzuki M
    Head Neck; 2013 Jun; 35(6):800-8. PubMed ID: 22791649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laryngeal Cancer, HPV DNA vs E6/E7 mRNA Test: A Systematic Review.
    Fusconi M; Campo F; Gallo A; Zambetti G; Martellucci S; Seccia A; de Vincentiis M
    J Voice; 2017 Mar; 31(2):248.e1-248.e5. PubMed ID: 27613249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas.
    Rietbergen MM; Snijders PJ; Beekzada D; Braakhuis BJ; Brink A; Heideman DA; Hesselink AT; Witte BI; Bloemena E; Baatenburg-De Jong RJ; Leemans CR; Brakenhoff RH
    Int J Cancer; 2014 May; 134(10):2366-72. PubMed ID: 24249631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P16INK4a expression, human papillomavirus, and survival in head and neck cancer.
    Smith EM; Wang D; Kim Y; Rubenstein LM; Lee JH; Haugen TH; Turek LP
    Oral Oncol; 2008 Feb; 44(2):133-42. PubMed ID: 17360226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus seropositivity and risks of head and neck cancer.
    Smith EM; Ritchie JM; Pawlita M; Rubenstein LM; Haugen TH; Turek LP; Hamsikova E
    Int J Cancer; 2007 Feb; 120(4):825-32. PubMed ID: 17131312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.